Submit Content
Get the latest delivered to your inbox
Privacy Policy

Now Reading

Biogen Leads From the Top With Disability Inclusion

Biogen Leads From the Top With Disability Inclusion

Published 12-03-21

Submitted by Biogen

Biogen CEO quote card observing International Day of Persons with Disabilities

December 3rd marks International Day of Persons with Disabilities, and we are glad to share that Biogen CEO Michel Vounatsos recently signed the Disability:IN’s CEO Letter on Disability Inclusion. We are proud we scored 100% on the Disability Equality Index for four consecutive years. We look forward to continued learning and growth to best support people with disabilities both within and outside of Biogen.

Learn more about our commitment for an accessible, inclusive workplace for all

Biogen Logo



At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain. We routinely post information that may be important to investors on our website at To learn more, please visit and follow us on social media - Twitter, LinkedIn, Facebook, YouTube.

More from Biogen

Join today and get the latest delivered to your inbox